SMS Pharmaceuticals P/E Ratio
SMSPHARMA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
40.9
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
40.9
Current Price
₹399.20
EPS (TTM)
₹8.16
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
15.74
Historical Range
7.68 - 25.31
Percentile
100.0%
Sector Context
Sector Average
47.54
Sector Median
25.5
Sector Rank
#11 of 139
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹10.14
Sept 2025
₹2.84
Mar 2025
₹2.40
Key P/E Ratio Insights for SMS Pharmaceuticals
- Stock appears overvalued with PE of 40.9, suggesting caution for new investments
- Current PE is 159.8% above historical average
- Trading at discount to sector average PE of 47.54
P/E Ratio Historical Trend for SMS Pharmaceuticals
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for SMS Pharmaceuticals
Additional stock information and data for SMSPHARMA
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 25.31 | 10.14 | ₹256.68 | NSE | High |
| 2024 | 15.35 | 7.81 | ₹119.85 | NSE | Moderate |
| 2023 | 18.24 | 4.58 | ₹83.55 | NSE | Moderate |
| 2021 | 12.77 | 9.3 | ₹118.75 | NSE | Low |
| 2020 | 7.68 | 5.42 | ₹41.65 | NSE | Low |
| 2019 | 15.11 | 4.56 | ₹68.90 | NSE | Moderate |
Sector P/E Ratio Comparison
Comparing SMS Pharmaceuticals with other companies in Healthcare sector
Sector Average
47.54
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.83 | ₹31 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.53 | ₹1,133 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Brooks Laboratories | BROOKS | 6.14 | ₹157 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.15 | ₹2,100 | Low |
| Galaxy Medicare | GML | 7.41 | ₹26 | Low |
| Vasundhara Rasayans | VRL | 9.35 | ₹34 | Low |